Efficacy of drug(ropivacaine heavy with or without dexmedetomidine) in spinal for uterus removal through vagina

Clinical Efficacy of Hyperbaric Ropivacaine Alone and with Dexmedetomidine in Spinal Anaesthesia for Vaginal Hysterectomy a double blind randomised control study - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/074085

Enrollment

Registered

2024-09-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N813- Complete uterovaginal prolapse Health Condition 2: N819- Female genital prolapse, unspecified Health Condition 3: O- Medical and Surgical Health Condition 4: N818- Other female genital prolapse Health Condition 5: N816- Rectocele Health Condition 6: N814- Uterovaginal prolapse, unspecified

Interventions

Intervention1: Spinal Anaesthesia with Dexmedetomidine as adjuvant to hyperbaric bupivacaine: spinal anaesthesia with dexmedetomidine 5mcg added to 26.25 mg (3.5 ml) of 0.75% hyperbaric ropivacine a

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1 and 2 posted for vaginal hysterectomy under spinal anaesthesia Patients having age between 40-60 yr Weight 40-80 kg Height more then 140cm will be included

Exclusion criteria

Exclusion criteria: Patient refusal. Contradictions to regional anaesthesia. History of significant co existing diseases, hypertension, impaired renal functions, rheumatoid arthritis, severe liver disease, anaemia, fused spine, coagulation disorder, diabetes, psychiatric illness, thyroid disease, malnourished patient and morbid obesity. Allergy to amide local anaesthesia and dexmedetomidine.

Design outcomes

Primary

Measure	Time frame
duration of analgesiaTimepoint: till patient complains of pain.	—

Secondary

Measure	Time frame
1. To compare Onset, extent & duration of sensory & motor block.Timepoint: upto six hours postoperatively	—

Countries

India

Contacts

Public ContactDr Jyoti

R.N.T medical college,udaipur

devendra.anaes@yahoo.in9829623028

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026